PROTALIX BIOTHERAPEUTICS, INC. (PLX)

[Spideyboy]

As I'm no expert in financial instruments and you seem to be clearer on this. Just applying logic, I don't quite understand how in your calculations under a 1/15 RS, that while the outstanding and restricted shares are divided by 15, but that the Authorised shares and the Available for financing are not divided by 15.

My understanding is that with a proposed 1/15 RS that all shares would be divided by 15, hence why the market cap of the company is not directly affected by an R/S?


Additionally something I am not clear about regarding the reduction of authorised shares from 350 million to 120 million, is that, would this be impacted by the 1/15 RS? And therefore are these specific numbers relating to the reduced number of authorised shares prior to any R/S as the R/S has not be voted to be able to be executed yet? And thus realistically speaking should we not be dividing these by 15 too?

Thanks for any insight on this!